Redefining metabolic syndrome as a fat storage condition based on studies of comparative physiology
- PMID: 23401356
- PMCID: PMC3660463
- DOI: 10.1002/oby.20026
Redefining metabolic syndrome as a fat storage condition based on studies of comparative physiology
Abstract
Objective: The metabolic syndrome refers to a constellation of signs including abdominal obesity, elevated serum triglycerides, low HDL-cholesterol, elevated blood pressure, and insulin resistance. Today approximately one third of the adult population has the metabolic syndrome. While there is little doubt that the signs constituting the metabolic syndrome frequently cluster, much controversy exists over the definition, pathogenesis, or clinical utility.
Design and methods: Here we present evidence from the field of comparative physiology that the metabolic syndrome is similar to the biological process that animals engage to store fat in preparation for periods of food shortage.
Results: We propose that the metabolic syndrome be changed to fat storage condition to more clearly align with its etiology. Obesity in humans is likely the consequences of both genetic predisposition (driven in part by thrifty genes) and environment. Recent studies suggest that the loss of the uricase gene may be one factor that predisposes humans to obesity today.
Conclusion: Understanding the process animals engage to switch from a lean insulin-sensitive to an obese insulin-resistant state may provide novel insights into the cause of obesity and diabetes in humans, and unique opportunities for reversing their pathology.
Copyright © 2012 The Obesity Society.
Conflict of interest statement
Dr Johnson is listed as an inventor on patent applications with the University of Florida related to lowering uric acid as a means for preventing or treating the metabolic syndrome. Dr Johnson and Dr Lanaspa are listed as inventors on patent applications from the University of Colorado on blocking fructose metabolism in the treatment of metabolic syndrome in response to carbohydrates. Finally, Dr. Johnson has a lay book, The Fat Switch (2012, Mercola.com) that discusses the role of fructose in metabolic syndrome in more detail. All other investigators have no conflicts.
Figures
Comment in
-
Comparative physiology and hyperuricemia as a causal factor for hypertension.Obesity (Silver Spring). 2014 Mar;22(3):623. doi: 10.1002/oby.20544. Epub 2013 Dec 19. Obesity (Silver Spring). 2014. PMID: 23804295 No abstract available.
References
-
- Kylin E. [Studies of the hypertension-hyperglycemia-hyperuricemia syndrome] Studien uber das Hypertonie-Hyperglykamie-hyperurikamiesyndrome. Zentralblatt fur innere Medizin. 1923;44:105–127.
-
- Herman JB, Medalie JH, Goldbourt U. Diabetes, prediabetes and uricaemia. Diabetologia. 1976;12:47–52. - PubMed
-
- Haller H. [Epidemiology and associated risk factors of hyperlipoproteinemia] Z Gesamte Inn Med. 1977;32:124–128. - PubMed
-
- Singer P. [Diagnosis of primary hyperlipoproteinemias] Z Gesamte Inn Med. 1977;32:128. contd. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
